Immunome files NDA for varegacestat in desmoid tumors
Immunome (IMNM) filed an NDA for varegacestat targeting desmoid tumors and highlighted its ROR1-focused ADC pipeline and innovative payload platform.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.